Company intelligence / Profile preview
HOOKIPA Pharma
Vienna, Austriahookipapharma.com ↗
- Ownership
- Public · HOOK
- Development stage
- Other
01
Overview
HOOKIPA Pharma develops novel immunotherapies using engineered arenaviruses to induce robust antigen-specific T cell responses. Its lead program HB‑200 targets HPV16+ head and neck cancer and has shown promising response rates in combination with Keytruda in early trials. The company also has a next-generation therapeutic vaccine for HIV in collaboration with Gilead that recently completed Phase Ib enrollment. Preclinical assets include a multi-KRAS targeted therapy for solid tumors[6][8][10].
- Therapeutic areas
- OncologyInfectious Diseases
- Modalities
- Viral vector-based immunotherapies (arenavirus vectors)Therapeutic vaccines
- Industry
- Biotech
02
Drug pipeline
12 assets11 more assets in the full pipeline.
03
Partnerships
Gilead Sciences – collaboration on functional cures for HIV and hepatitis B[3][4][6]Roche – previously collaborated on KRAS-mutant cancers; partnership ended earlier in the year[8]
Beyond the preview
Go deeper on HOOKIPA Pharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on HOOKIPA Pharma.